The role of stimulants in the treatment of preschool children with attention-deficit hyperactivity disorder

Christopher J Kratochvil, Laurence L. Greenhill, John S. March, William J. Burke, Brigette S. Vaughan

Research output: Contribution to journalReview article

29 Citations (Scopus)

Abstract

The symptoms of attention-deficit hyperactivity disorder (ADHD) can have an early onset, beginning before the age of 6 years. Despite the significant number of preschool-aged children that can be diagnosed with ADHD, there are limited controlled data available on the pharmacological interventions being increasingly used in this population. A 1990 review showed that 34% of paediatricians and 15% of family physicians had prescribed psychostimulant medications to preschoolers with ADHD, and pharmacoepidemiological studies indicate growing use of stimulants in preschoolers during the 1990s. Unfortunately, only six controlled trials, with a total enrolment of less than 200 children, have been conducted using these drugs in preschoolers. While these small studies provide some evidence of benefit from the use of methylphenidate in preschoolers with ADHD, more data are critically needed. Practice parameters developed by the American Academy of Child & Adolescent Psychiatry and the American Academy of Pediatrics provide some guidance regarding the diagnosis and treatment of young children with ADHD, but are mainly based upon research in children of primary-school age. The ongoing PATS (Preschool ADHD Treatment Study), funded by the National Institute of Mental Health, will provide important clinical guidance for diagnostic considerations and intervention strategies for children with ADHD aged 3-5 years. Pending the release of data from the PATS study, clinicians must rely on developmental assessment skills, available standardised rating instruments, reports about the child from multiple informants, and knowledge of the risks and benefits of available pharmacological and behavioural treatments, in order to treat preschool children with ADHD effectively.

Original languageEnglish (US)
Pages (from-to)957-966
Number of pages10
JournalCNS Drugs
Volume18
Issue number14
DOIs
StatePublished - Dec 20 2004

Fingerprint

Preschool Children
Attention Deficit Disorder with Hyperactivity
Therapeutics
Pharmacology
Adolescent Psychiatry
National Institute of Mental Health (U.S.)
Methylphenidate
Family Physicians
Pediatrics
Research
Pharmaceutical Preparations
Population

ASJC Scopus subject areas

  • Clinical Neurology
  • Psychiatry and Mental health
  • Pharmacology (medical)

Cite this

The role of stimulants in the treatment of preschool children with attention-deficit hyperactivity disorder. / Kratochvil, Christopher J; Greenhill, Laurence L.; March, John S.; Burke, William J.; Vaughan, Brigette S.

In: CNS Drugs, Vol. 18, No. 14, 20.12.2004, p. 957-966.

Research output: Contribution to journalReview article

Kratochvil, Christopher J ; Greenhill, Laurence L. ; March, John S. ; Burke, William J. ; Vaughan, Brigette S. / The role of stimulants in the treatment of preschool children with attention-deficit hyperactivity disorder. In: CNS Drugs. 2004 ; Vol. 18, No. 14. pp. 957-966.
@article{ae0611a53ff2454c9a81f234dafa3ec0,
title = "The role of stimulants in the treatment of preschool children with attention-deficit hyperactivity disorder",
abstract = "The symptoms of attention-deficit hyperactivity disorder (ADHD) can have an early onset, beginning before the age of 6 years. Despite the significant number of preschool-aged children that can be diagnosed with ADHD, there are limited controlled data available on the pharmacological interventions being increasingly used in this population. A 1990 review showed that 34{\%} of paediatricians and 15{\%} of family physicians had prescribed psychostimulant medications to preschoolers with ADHD, and pharmacoepidemiological studies indicate growing use of stimulants in preschoolers during the 1990s. Unfortunately, only six controlled trials, with a total enrolment of less than 200 children, have been conducted using these drugs in preschoolers. While these small studies provide some evidence of benefit from the use of methylphenidate in preschoolers with ADHD, more data are critically needed. Practice parameters developed by the American Academy of Child & Adolescent Psychiatry and the American Academy of Pediatrics provide some guidance regarding the diagnosis and treatment of young children with ADHD, but are mainly based upon research in children of primary-school age. The ongoing PATS (Preschool ADHD Treatment Study), funded by the National Institute of Mental Health, will provide important clinical guidance for diagnostic considerations and intervention strategies for children with ADHD aged 3-5 years. Pending the release of data from the PATS study, clinicians must rely on developmental assessment skills, available standardised rating instruments, reports about the child from multiple informants, and knowledge of the risks and benefits of available pharmacological and behavioural treatments, in order to treat preschool children with ADHD effectively.",
author = "Kratochvil, {Christopher J} and Greenhill, {Laurence L.} and March, {John S.} and Burke, {William J.} and Vaughan, {Brigette S.}",
year = "2004",
month = "12",
day = "20",
doi = "10.2165/00023210-200418140-00001",
language = "English (US)",
volume = "18",
pages = "957--966",
journal = "CNS Drugs",
issn = "1172-7047",
publisher = "Adis International Ltd",
number = "14",

}

TY - JOUR

T1 - The role of stimulants in the treatment of preschool children with attention-deficit hyperactivity disorder

AU - Kratochvil, Christopher J

AU - Greenhill, Laurence L.

AU - March, John S.

AU - Burke, William J.

AU - Vaughan, Brigette S.

PY - 2004/12/20

Y1 - 2004/12/20

N2 - The symptoms of attention-deficit hyperactivity disorder (ADHD) can have an early onset, beginning before the age of 6 years. Despite the significant number of preschool-aged children that can be diagnosed with ADHD, there are limited controlled data available on the pharmacological interventions being increasingly used in this population. A 1990 review showed that 34% of paediatricians and 15% of family physicians had prescribed psychostimulant medications to preschoolers with ADHD, and pharmacoepidemiological studies indicate growing use of stimulants in preschoolers during the 1990s. Unfortunately, only six controlled trials, with a total enrolment of less than 200 children, have been conducted using these drugs in preschoolers. While these small studies provide some evidence of benefit from the use of methylphenidate in preschoolers with ADHD, more data are critically needed. Practice parameters developed by the American Academy of Child & Adolescent Psychiatry and the American Academy of Pediatrics provide some guidance regarding the diagnosis and treatment of young children with ADHD, but are mainly based upon research in children of primary-school age. The ongoing PATS (Preschool ADHD Treatment Study), funded by the National Institute of Mental Health, will provide important clinical guidance for diagnostic considerations and intervention strategies for children with ADHD aged 3-5 years. Pending the release of data from the PATS study, clinicians must rely on developmental assessment skills, available standardised rating instruments, reports about the child from multiple informants, and knowledge of the risks and benefits of available pharmacological and behavioural treatments, in order to treat preschool children with ADHD effectively.

AB - The symptoms of attention-deficit hyperactivity disorder (ADHD) can have an early onset, beginning before the age of 6 years. Despite the significant number of preschool-aged children that can be diagnosed with ADHD, there are limited controlled data available on the pharmacological interventions being increasingly used in this population. A 1990 review showed that 34% of paediatricians and 15% of family physicians had prescribed psychostimulant medications to preschoolers with ADHD, and pharmacoepidemiological studies indicate growing use of stimulants in preschoolers during the 1990s. Unfortunately, only six controlled trials, with a total enrolment of less than 200 children, have been conducted using these drugs in preschoolers. While these small studies provide some evidence of benefit from the use of methylphenidate in preschoolers with ADHD, more data are critically needed. Practice parameters developed by the American Academy of Child & Adolescent Psychiatry and the American Academy of Pediatrics provide some guidance regarding the diagnosis and treatment of young children with ADHD, but are mainly based upon research in children of primary-school age. The ongoing PATS (Preschool ADHD Treatment Study), funded by the National Institute of Mental Health, will provide important clinical guidance for diagnostic considerations and intervention strategies for children with ADHD aged 3-5 years. Pending the release of data from the PATS study, clinicians must rely on developmental assessment skills, available standardised rating instruments, reports about the child from multiple informants, and knowledge of the risks and benefits of available pharmacological and behavioural treatments, in order to treat preschool children with ADHD effectively.

UR - http://www.scopus.com/inward/record.url?scp=10044235041&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=10044235041&partnerID=8YFLogxK

U2 - 10.2165/00023210-200418140-00001

DO - 10.2165/00023210-200418140-00001

M3 - Review article

VL - 18

SP - 957

EP - 966

JO - CNS Drugs

JF - CNS Drugs

SN - 1172-7047

IS - 14

ER -